Expert Opinion on Pharmacotherapy

Papers
(The H4-Index of Expert Opinion on Pharmacotherapy is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Pharmacotherapy developments in autophagy inhibitors for bladder cancer40
Antidepressant medications in women aged 40 and older and the risk of fragility fractures: a systematic literature review and meta-analysis39
The pharmacological treatment and management of hyperhidrosis38
Promising therapies for adults with symptomatic obstructive hypertrophic cardiomyopathy: 2023 and beyond36
Perspectives on the advances in the pharmacotherapeutic management of Duchenne muscular dystrophy35
Oral anticoagulation therapy in the setting of liver disease35
A 2023 update on the advancements in the treatment of agitation in Alzheimer’s disease34
Current treatment options for Mycobacterium marinum cutaneous infections32
Real-world safety and effectiveness of roxadustat in patients with anemia of chronic kidney disease: interim results from a post-marketing surveillance study in Japan29
Advances in the management of obstructive hypertrophic cardiomyopathy: The role of mavacamten28
Evaluating the safety and efficacy of seladelpar for adults with primary biliary cholangitis25
Chemotherapy in resectable or potentially resectable colon cancer with liver metastases24
Efficacy of 3-day versus 5-day aprepitant regimens for long-delayed chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based chemotherapy24
Rheumatoid arthritis in Latin America: pharmacotherapy and clinical challenges24
An overview of mineralocorticoid receptor antagonists as a treatment option for patients with heart failure: the current state-of-the-art and future outlook23
Comprehensive overview of the available pharmacotherapy for the treatment of non-neurogenic overactive bladder in children22
How useful is chemotherapy for atypical and anaplastic meningiomas?21
GnRH agonists and antagonists in therapy of symptomatic uterine fibroids – current roles and future perspectives21
Pharmacotherapeutic options in pediatric obesity: an urgent call for further research20
Current and emerging pharmacotherapies for the treatment of pulmonary arterial hypertension in infants20
0.063230991363525